Utah Medical Products (UTMD) executive compensation, 2026 proxy

Kevin L. Cornwell, Chairman & CEO, was paid $341,709 in fiscal 2025, down 25% from $455,080 the year before. The CEO-to-median-employee pay ratio was 8:1, on median employee pay of $43,500.

Filed
April 2, 2026
Annual meeting
May 1, 2026
Pay year
fiscal 2025
Named executives
2
CEO total pay
$341,709-25% vs prior year
CEO to median employee
8:1median $43,500
CEO Total Compensation
$341,709Decreased 25% from prior year
CEO Base Salary
$87,000Reduced to half rate for 2025
CEO Option Awards
$246,750Value of option awards
CEO Pay Ratio
8:1Ratio to median employee pay
Median Employee Pay
$43,500Annual total compensation

How Cornwell was paid

$341,709 in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary25%Option awards72%Non-equity incentive2%

Named executive officers

ExecutiveTotal
Kevin L. CornwellChairman & CEO$341,709
Brian L. KoopmanPrincipal Financial Officer$179,077

What changed and why

  • 25%CEO total compensation decreased 25% to $341,709 due to lower option awards and management bonus.
  • $87,000,CEO base salary was set at $87,000, representing half of the previous annual rate for the remainder of 2025.
  • $247KOption awards for the CEO decreased to $246,750 from $289,800 in the prior year.
  • $7,959,Non-equity incentive compensation for the CEO was $7,959, reflecting lower consolidated earnings before tax.
  • $179KPrincipal Financial Officer total compensation increased to $179,077 from $167,793 in the prior year.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.